CVS says GLP-1s save money when priced below $350 per month
Story summaryThe analysis looked at patients who were newly taking highly popular GLP-1 medicines — which mimic the GLP-1 hormone and reduce appetite — from Eli Lilly and Novo Nordisk, and compared them to similar patients who were not taking the drugs.
Read at New York PostOpens the original publisher in a new tab. Full articles belong to their publishers; a subscription may be required.